Skip to main content

HLA DRB1 CWD Resolution, DRB3,4,5 Intermediate Resolution

CPT

81376; 81382

  • Share
  • Print
  • Updated on 04/14/2025

Test Details

Methodology

HLA results are obtained using Next Generation Sequencing (NGS).

Sequence-based typing (SBT), sequence-specific oligonucleotide probes (SSOP), and/or sequence-specific primers (SSP) as needed to obtain the required resolution.

HLA results are obtained using Next Generation Sequencing (NGS).

Result Turnaround Time

3 - 7 days

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

Related Documents

Use

This test yields a CWD DRB1 result with low to intermediate resolution DRB3,4, and 5. DRB1 antigens may be correlated with certain disease states or other clinical conditions. Indicate in clinical information which antigen(s) is of interest. Also used for screening of transplant candidates and potential donors, transfusion of specifically compatible blood products, among others.

CWD resolution typing for HLA will meet the following criteria:

1. The typing must contain only one unambiguously assigned genotype, or

2. The typing may contain multiple alternative genotypes if one includes two Common and Well Documented (CWD) alleles and the others do not include any CWD allele. Alleles that encode identical protein sequences in the antigen recognition site (ARS) will not be resolved even if they are CWD.

3. Rare or unusual allele combinations may not be ruled out.

4. Allele codes will be reported to include those alleles that are not ruled out.

Common and well documented alleles are defined by Cano et al1 and Mack et al.2

Special Instructions

If you have questions, please call 800-533-1037 (HLA customer service) for assistance in selecting the proper HLA test for the patient.

Limitations

This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration.

This test was developed, and its performance characteristics determined, by LabCorp. It has not been cleared or approved by the US Food and Drug Administration (FDA).

This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration.

Specimen Requirements

Specimen

Whole blood

Volume

7 mL

Minimum Volume

3 mL

Container

Lavender-top (EDTA) tube

Storage Instructions

Maintain specimen at room temperature; protect from extreme heat or cold. Do not freeze.

Causes for Rejection

Hemolyzed specimen; clotted specimen; wrong specimen container

Footnotes

1. Cano P, Klitz W, Mack SJ, et al. Common and well-documented HLA alleles: Report of the ad-hoc committee of the American Society for Histocompatibility and Immunogenetics. Hum Immunol. 2007 May; 68(5):392-417. 17462507
2. Mack SJ, Cano P, Hollenbach JA, et al. Common and Well-Documented HLA Alleles: 2012 Update to the CWD Catalogue. Tissue Antigens. 2013 Apr; 81(4):194-203. 23510415

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
176098 HLA-DRB1 (CWD) DRB345 (IR) 166215 DRB1 57298-2
176098 HLA-DRB1 (CWD) DRB345 (IR) 166223 DRB1 57298-2
176098 HLA-DRB1 (CWD) DRB345 (IR) 166226 DRB3 59022-4
176098 HLA-DRB1 (CWD) DRB345 (IR) 166229 DRB3 59022-4
176098 HLA-DRB1 (CWD) DRB345 (IR) 166227 DRB4 59021-6
176098 HLA-DRB1 (CWD) DRB345 (IR) 166230 DRB4 59021-6
176098 HLA-DRB1 (CWD) DRB345 (IR) 166228 DRB5 59020-8
176098 HLA-DRB1 (CWD) DRB345 (IR) 166232 DRB5 59020-8
176098 HLA-DRB1 (CWD) DRB345 (IR) 167384 HLA Methodology 49549-9
Order Code176098
Order Code NameHLA-DRB1 (CWD) DRB345 (IR)
Order Loinc
Result Code166215
Result Code NameDRB1
UofM
Result LOINC57298-2
Order Code176098
Order Code NameHLA-DRB1 (CWD) DRB345 (IR)
Order Loinc
Result Code166223
Result Code NameDRB1
UofM
Result LOINC57298-2
Order Code176098
Order Code NameHLA-DRB1 (CWD) DRB345 (IR)
Order Loinc
Result Code166226
Result Code NameDRB3
UofM
Result LOINC59022-4
Order Code176098
Order Code NameHLA-DRB1 (CWD) DRB345 (IR)
Order Loinc
Result Code166229
Result Code NameDRB3
UofM
Result LOINC59022-4
Order Code176098
Order Code NameHLA-DRB1 (CWD) DRB345 (IR)
Order Loinc
Result Code166227
Result Code NameDRB4
UofM
Result LOINC59021-6
Order Code176098
Order Code NameHLA-DRB1 (CWD) DRB345 (IR)
Order Loinc
Result Code166230
Result Code NameDRB4
UofM
Result LOINC59021-6
Order Code176098
Order Code NameHLA-DRB1 (CWD) DRB345 (IR)
Order Loinc
Result Code166228
Result Code NameDRB5
UofM
Result LOINC59020-8
Order Code176098
Order Code NameHLA-DRB1 (CWD) DRB345 (IR)
Order Loinc
Result Code166232
Result Code NameDRB5
UofM
Result LOINC59020-8
Order Code176098
Order Code NameHLA-DRB1 (CWD) DRB345 (IR)
Order Loinc
Result Code167384
Result Code NameHLA Methodology
UofM
Result LOINC49549-9